Objective evaluation for changes of dopamine transporter using PET with [18F]FE-PE2I among psychiatric illnesses.
Not Applicable
- Conditions
- healthy adults, dementia with lewy body (DLB), schizophrenia, mood disorder, REM sleep behavior disorder (RBD), Attention deficit hyperactivity disorder (ADHD)
- Registration Number
- JPRN-UMIN000006962
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
- With past or current history of serious medical illness and/or brain organic diseases - Subject who is contraindicated for the use of MRI - With past or current history of severe liver disease, kidney disease, heart disease, allergy, or severe drug allergy - Subjects who are judged as not suitable for participation in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quantitative measurement of brain dopamine transporter binding
- Secondary Outcome Measures
Name Time Method brain MRI